FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11505611000001102: Humatin 250mg capsules (Pfizer Ltd) 28 capsule (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42269001000001116 Humatin 250mg capsules (Pfizer Ltd) 28 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
43207001000001119 Humatin 250mg capsules (Imported (Germany)) 28 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction imported true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Is a Paromomycin 250mg capsules 28 capsule true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Is pack of Humatin 250mg capsules (Pfizer Ltd) false Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Has active ingredient Paromomycin sulfate false Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Has active ingredient Paromomycin false Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Has active ingredient Antiparasite agent false Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Has AMP Humatin 250mg capsules (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Paromomycin true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Has specific active ingredient Paromomycin sulfate true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Humatin 250mg capsules (Pfizer Ltd) 28 capsule Has basis of strength substance Paromomycin true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start